Herein, we present a case of a successful treatment of persistent type 2 endoleaks associated with aneurysmal sac enlargement after endovascular aneurysm repair in an elderly patient. We confirmed the diagnosis by abdominal computed tomography and selective angiography revealing an 11.0-cm aneurysm sac with type 2 endoleaks. An attempt for the endovascular embolization of collateral arteries was unsuccessful due to anatomic variations and their multiple complex communications. Instead, transperitoneal sacotomy and direct suturing on the feeding target vessels was successfully performed without any endograft damage. In conclusion, sacotomy appears to be a feasible therapeutic substitute where endovascular or other techniques have a high risk of failure and lead to unsuccessful results. that was measured to be 110 mm in size (Fig. 1) . First, we performed selective angiography with left internal iliac artery catheterization for coil embolization. An angiography verified a contrast material entering the aneurysm sac via the lumbar arteries (Fig. 2) . We subsequently proceeded to the coli em-
. First, we performed selective angiography with left internal iliac artery catheterization for coil embolization. An angiography verified a contrast material entering the aneurysm sac via the lumbar arteries (Fig. 2) . We subsequently proceeded to the coli em-− 168 − bolization of the penetrating lumbar arteries. However, an attempt for the endoluminal embolization of the lumbar arteries was unsuccessful due to anatomic variations and their complex interrelations, which impeded the access to the endovascular catheter.
Therefore, we adopted a surgical approach. A midline laparotomy was performed to expose the aneurysm sac after further informed consent. We cautiously dissected around both the renal arteries to secure the route for emergency aortic cross clamping. Prior to opening the aneurysm sac, a 16-gauge catheter was inserted, confirming the sac to be rather solid to the touch and the presence of a serosanguineous fluid. Upon opening the sac, old hematoma and blood clots were identified, and the endovascular graft was intact; otherwise, pulsatile backflow bleeding from several lumbar arteries and the inferior mesenteric artery was noted. We evacuated all the blood clots and thrombi, and then, the two lumbar arteries on the posterior wall of the aneurysm sac and the inferior mesenteric artery were oversewn with a 5-0 prolene suture. After confirming that there was no evidence of any other source of bleeding, we also applied autologous fibrin glue at the suture sites for hemostasis. The remnant sac was then carefully closed with an absorbable suture to protect the endograft. 
DISCUSSION
Nowadays, EVAR has been considered a safe and effective treatment for abdominal AAAs. EVAR has many benefits, which include relatively low operative mortality, morbidities, relatively short operative time, and short duration of hospitalization. In general, the early and midterm outcomes of EVAR are not poor; however, long-term durability remains elusive due to the presence of endoleaks. An endoleak is the existence of a continuous blood flow outside the endograft and within the aneurysmal sac. In general, patients get a medical check up such as the physical examination, the abdominal simple X-ray, and the contrast enhanced CTA at the 1 month after EVAR, at 6 month and yearly thereafter. There are several types of endoleaks with different causes requiring specific individual plans. Endoleaks have been reported to be up to 60% of the complications after EVAR and are responsible for more than 45% of all reinterventions [1] . Type 1 or type 3 endoleaks could be considered a failure of endovascular repair and require immediate reintervention because of a highly potential aortic aneurysm rupture, whereas type 2 endoleaks have been regarded as a benign condition. Some studies have reported that type 2 endoleaks occurs in 20% to 30% of the patients at some interval after EVAR but does not require further treatment because they are usually transient and resolve by themselves [2] . However, other researchers advocate that more aggressive management is needed to control the type 2 endoleaks persisting for more than 6 months, irrespective of the changes in the aneurysmal sac [1] .
Although the significance of asymptomatic type 2 endoleaks has been debated, persistent type 2 endoleaks associated with an increase in the diameter of the aneurysm sac actually in- Further treatment is usually recommended to prevent rupture if continuous endoleaks persist for more than 6 months or an aneurysm sac enlargement (＞5 mm) is identified after EVAR [4] . The most common technique for type 2 endoleaks is the transarterial embolization of the feeding vessels with coils or glue materials. Transarterial embolization is mostly targeted at the lumbar arteries, hypogastric arteries, and inferior mesentery artery, which are directly concerned with the type 2 endoleaks. However, selective catheterization of these target vessels may be technically difficult, even when multiple small complex communicating vessels are intertwined.
Although the failure and recurrence rates after the transarterial embolization can be as high as 80%, another technique that embolizes both the feeding and the draining vessels 
